AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Accounts-Payable" stands at 23.01 Billion United States Dollars as of 06/30/2026.
As of the end of AstraZeneca PLC's second quarter, the item "Accounts Payable" stands at 23.01 Billion USD. This represents an increase of 2.25 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -4.06 percent compared to the value the year prior.
The 1 year change in percent is -4.06.
The 3 year change in percent is 16.59.
The 5 year change in percent is 29.80.
The 10 year change in percent is 124.31.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Accounts Payable | 905,699,262,464.00 |
![]() | Johnson & Johnson - Accounts Payable | 486,508,953,600.00 |
![]() | AbbVie Inc - Accounts Payable | 399,570,305,024.00 |
![]() | Roche Holding AG - Accounts Payable | 317,433,206,677.55 |
![]() | Novartis AG - Accounts Payable | 255,096,620,580.91 |